386 related articles for article (PubMed ID: 7582848)
1. Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.
Gajda M; Tyloch F; Jóźwicki W; Tyloch J; Sujkowska R; Skok Z
Int J Occup Med Environ Health; 1995; 8(2):103-8. PubMed ID: 7582848
[TBL] [Abstract][Full Text] [Related]
2. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
4. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
[TBL] [Abstract][Full Text] [Related]
5. Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma.
Hakenberg OW; Fuessel S; Richter K; Froehner M; Oehlschlaeger S; Rathert P; Meye A; Wirth MP
Urology; 2004 Dec; 64(6):1121-6. PubMed ID: 15596183
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of CEA in urine of patients with bladder carcinoma.
Persijn JP; Korsten CB; Renaud J
Z Klin Chem Klin Biochem; 1974 May; 12(5):232. PubMed ID: 4440123
[No Abstract] [Full Text] [Related]
7. [Levels of carcinoembryonic antigen and alpha fetoproteins in urine of of workers at the Bydgoszcz industrial works "Pasamon"].
Gajda M; Tyloch F; Tyloch J; Skok Z; Sujkowska R
Med Pr; 1993; 44(3):255-9. PubMed ID: 7694033
[TBL] [Abstract][Full Text] [Related]
8. [The diagnostic value of flow cytometric DNA analysis in bladder cancer--comparison with conventional cytology].
Kawasaki T
Hinyokika Kiyo; 1991 Nov; 37(11):1481-9. PubMed ID: 1767770
[TBL] [Abstract][Full Text] [Related]
9. [The value of urine sediment cytomorphology in the ambulatory differential diagnosis of hematuria].
Obroniecka I; Rojewska J; Wańkowicz Z
Pol Merkur Lekarski; 1998 Nov; 5(29):285-7. PubMed ID: 10101502
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of urinary ferritin, CEA and beta 2-MG determinations in patients with urinary tract malignancies].
Ohashi T; Tohjoh S; Matsumura Y; Ohmori H; Suyama B; Hironaka K
Hinyokika Kiyo; 1983 Feb; 29(2):131-9. PubMed ID: 6375312
[TBL] [Abstract][Full Text] [Related]
11. Screening tests for the detection of bladder cancer.
Betkerur V; Hliang V; Baumgartner G; Rao R; Ablin RJ; Guinan PD
Allergol Immunopathol (Madr); 1980; 8(3):169-76. PubMed ID: 7405763
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].
Nagata Y; Kinoshita H; Kawamura N; Sasadaira S
Hinyokika Kiyo; 1985 Nov; 31(11):1931-7. PubMed ID: 4091136
[TBL] [Abstract][Full Text] [Related]
13. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
[TBL] [Abstract][Full Text] [Related]
14. Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer.
Sánchez-Carbayo M; Urrutia M; Silva JM; Romaní R; De Buitrago JM; Navajo JA
J Urol; 2001 May; 165(5):1462-7. PubMed ID: 11342897
[TBL] [Abstract][Full Text] [Related]
15. Urine carcinoembryonic antigen levels are more useful than serum levels for early detection of Bilharzial and non-Bilharzial urinary bladder carcinoma: observations of 43 Egyptian cases.
Saied GM; El-Metenawy WH; Elwan MS; Dessouki NR
World J Surg Oncol; 2007 Jan; 5():4. PubMed ID: 17224047
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
Feil G; Zumbrägel A; Päulgen-Nelde HJ; Hennenlotter J; Maurer S; Krause S; Bichler KH; Stenzl A
Anticancer Res; 2003; 23(2A):963-7. PubMed ID: 12820331
[TBL] [Abstract][Full Text] [Related]
17. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P
Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859
[TBL] [Abstract][Full Text] [Related]
18. Urine cytology: early diagnosis of induced carcinoma of the rat urinary bladder.
Reznik G; Brennan LM; Creasia DA
Anticancer Res; 1981; 1(6):389-92. PubMed ID: 7344612
[TBL] [Abstract][Full Text] [Related]
19. [Influence of blood cells in urine samples on results of screening for urothelial carcinoma with NMP22 bladder chek].
Ueda Y; Kawaguchi R; Takiuchi H; Kokura K; Yoshimoto T; Mitsui Y; Suzuki T; Jun Q; Higuchi Y; Maruyama T; Kondoh N; Nozima M; Yamamoto S; Shima H
Hinyokika Kiyo; 2009 Feb; 55(2):71-4. PubMed ID: 19301610
[TBL] [Abstract][Full Text] [Related]
20. [Urine examination for tumor cells using quantitative immunocytochemistry. Antibodies to a CEA-like antigen].
Sautner D; Saeger W
Fortschr Med; 1995 May; 113(14):207-9. PubMed ID: 7607589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]